(Q46831933)

25 December 2017

title

Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO. (English)

1 reference

25 December 2017

author

Percy A. Knolle

18

1 reference

25 December 2017

Gerhard Wingender

1

object named as

Gerhard Wingender

1 reference

25 December 2017

Natalio Garbi

2

1 reference

25 December 2017

Beatrix Schumak

3

1 reference

25 December 2017

Frank Jüngerkes

4

1 reference

25 December 2017

Elmar Endl

5

1 reference

25 December 2017

Dagmar von Bubnoff

6

1 reference

25 December 2017

Julia Steitz

7

1 reference

25 December 2017

Jörg Striegler

8

1 reference

25 December 2017

Gerd Moldenhauer

9

1 reference

25 December 2017

Thomas Tüting

10

1 reference

25 December 2017

Antje Heit

11

1 reference

25 December 2017

Katharina M Huster

12

1 reference

25 December 2017

Osamu Takikawa

13

1 reference

25 December 2017

Shizuo Akira

14

1 reference

25 December 2017

Dirk H Busch

15

1 reference

25 December 2017

Hermann Wagner

16

1 reference

25 December 2017

Günter J Hämmerling

17

1 reference

25 December 2017

Andreas Limmer

19

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

25 December 2017

European Journal of Immunology

published in

1 reference

25 December 2017

volume

36

1 reference

25 December 2017

page(s)

12-20

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

FcepsilonRI induces the tryptophan degradation pathway involved in regulating T cell responses

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Innate immune sensing of microbial infection: the mechanism and the therapeutic challenge

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Toll-like receptor control of the adaptive immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Toll-like receptors and dendritic cells: for whom the bug tolls

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Immunostimulatory sequence oligodeoxynucleotide-based vaccination and immunomodulation: two unique but complementary strategies for the treatment of allergic diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Immunotherapeutic uses of CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Bone marrow as a priming site for T-cell responses to blood-borne antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Cross-presentation of oral antigens by liver sinusoidal endothelial cells leads to CD8 T cell tolerance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

A Toll-like receptor recognizes bacterial DNA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Tryptophan and the immune response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Inhibition of experimental asthma by indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

IDO expression by dendritic cells: tolerance and tryptophan catabolism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

T cell receptor antagonist peptides induce positive selection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

TLR9-Dependent Recognition of MCMV by IPC and DC Generates Coordinated Cytokine Responses that Activate Antiviral NK Cell Function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Systemic T cell expansion during localized viral infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

In vivo bioluminescence imaging for integrated studies of infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535602

7 January 2021

Identifiers

DOI

10.1002/EJI.200535602

1 reference

25 December 2017

PubMed ID

16323249

1 reference

25 December 2017